))
From The Heart - (SGLT2 inhibitors) Ep#3: From diabetes to heart failure!
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on April 04, 2024 11:08 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 337666494 series 3322188
Вміст надано RAS LSS Consulting. Весь вміст подкастів, включаючи епізоди, графіку та описи подкастів, завантажується та надається безпосередньо компанією RAS LSS Consulting або його партнером по платформі подкастів. Якщо ви вважаєте, що хтось використовує ваш захищений авторським правом твір без вашого дозволу, ви можете виконати процедуру, описану тут https://uk.player.fm/legal.
Today’s podcast is the third in the series of five episodes of “From The Heart - Tying the threads through the evolving body of evidence in HF “. Today's episode is focused on a new class of drugs in heart failure - The Sodium Glucose Like Transporter 2 inhibitors or as they are more commonly known as SGLT2is
For those who have just tuned in to our podcast series for the first time, please do listen into our first episode where we discussed about the basics of heart failure and a brief historical view of heart failure therapies (Link https://www.buzzsprout.com/1947788/10351733-from-the-heart-ep-1-introduction-to-heart-failure-and-a-brief-overview-of-evolving-hf-treatments.mp3?download=true)
The second episode discussed about Entresto, its mechanism of action and clinical evidence in heart failure. (Link https://www.buzzsprout.com/1947788/10498068-from-the-heart-ep-2-entresto-the-first-arni-approved-for-heart-failure.mp3?download=true)
7 епізодів
Поширити
